Patent Application
20070213765
This invention relates to a device, a system, and a method for treating vascular disease. In particular, this invention relates to the occlusion of blood flow through a stenotic region and treatment of the region.
Atherosclerosis or vascular disease is the leading cause of death in the world today. It is a disease of the arteries whereby deposits (plaque) build up over time in the walls of the arteries, restricting oxygenated blood flow to vital organs such as the heart, brain and other bodily tissue. A number of medical procedures have been developed to treat vascular disease such as Coronary Artery By-Pass Grafting (CABG) and Percutaneous Balloon Angioplasty (PTCA) and Stenting. These procedures are intended to restore normal flow through the arteries.
In the case of CABG, the saphenous vein is harvested from the leg and used as a conduit to by-pass blood flow from the aorta to a point distal to an obstruction in a coronary artery. After a number of years, these grafts become diseased, and treatment of the graft is needed to improve blood flow. Treatment of these degenerated grafts with PTCA or Stenting is associated with a high incidence of embolic material (vessel deposits) released distally. This can result in a no-flow condition and myocardial infarction. Similarly, treatment of carotid arteries and renal arteries by PTCA and Stenting can cause release of embolic material. In the case of the carotid artery, emboli released can result in a stroke. In the case of the renal artery, emboli release can result in the renal infarct and reduced renal function. There is a risk of embolic material being released with any balloon expansion or passage of a treatment device through a diseased section of a vessel, with undesirable results to the patient. Thus, it is highly desirable to prevent embolic material from being released during treatment of vascular disease.
The use of embolic protection devices has recently improved the outcome for treatment of these diseased grafts and arterial restrictions. There are two major approaches to embolic protection. In either case the devices are delivered to the area of treatment in the conventional means through a guide catheter or elongated sheath.
The first approach involves crossing the obstruction or diseased vessel with a deflated balloon affixed to the distal end of a hollow guidewire. The balloon segment is placed distal to the arterial segment to be treated, and the balloon is inflated to occlude flow of blood in the vessel. The PTCA or Stenting treatment is then performed over the hollow wire and any embolic material is prevented from moving beyond the distal occlusion balloon. After completion of the treatment, a suction catheter is placed into the vessel such that the distal tip is near the balloon. Suction is applied to the catheter tip and embolic material is removed from the vessel.
The second approach involves a filter mounted on a guidewire and sheathed in a delivery catheter. The sheathed filter is placed in the artery distal to the treatment site. The filter is then deployed through the sheath and expands outward adjacent the vessel wall to channel blood flow into the filter. The treatment device is then advanced over the guidewire, and any emboli generated during treatment is directed by the blood flow into the filter. The filter retains embolic material greater in size than the filter pore size. After treatment, a recovery catheter is advanced distally to a location proximal to the filter and the filter pulled proximally. The filter closes and/or the filter is drawn completely into a lumen of the retrieval catheter. The system with captured emboli is then withdrawn from the body.
A balloon occlusion approach can be problematic because no blood is flowing through the vessel during use of the treatment device and ischemia can develop quickly, particularly in saphenous vein grafts. The procedure must be conducted swiftly to prevent undue patient pain. There is also no assurance that all trapped emboli are removed by suction.
A filter approach can be problematic because particles smaller than the filter pore size will pass through the filter and may cause embolic events or consequence, particularly in the brain. There is also no assurance that trapped emboli will not be squeezed through the filter mesh during recovery.
Recent clinical trials show that both types of embolic protection devices reduce the occurrence of embolic events by about half in the case of saphenous vein grafts. Clinical trials currently are assessing the benefit in carotid and other arterial treatments.
Unfortunately, these approaches to embolic protection do not eliminate embolic events entirely because passage of the protection device or the catheter delivering the device across the diseased section of the vessel or lesion can dislodge embolic material prior to deployment of the device. Thus, it would be highly desirable to use a device or method that would prevent release of embolic material during passage of the embolic protection system through the vessel lesion to the deployment location. One prior art attempt to solve this problem is disclosed in U.S. Pat. No. 6,348,062 (Hopkins et al.). In this approach a PTCA balloon is inflated proximal to the treatment site (lesion) to create stasis in the vessel. Emboli liberated on lesion crossing cannot be transported distally because there is no flow. A distal protection filter is then deployed and flow in the vessel is re-established. Any emboli created during lesion crossing by the distal protection device are prevented from flowing distally. The disadvantages of this system are that a treatment balloon must be advanced into the vessel prior to creating stasis, and advancement of this balloon may liberate emboli. Further, initial treatment with a balloon is not appropriate therapy for all procedures. For example, it may be more appropriate to initially debulk a vessel using atherectomy or thrombectomy by methods commonly used in the art. Finally, it is known that even passage of a guidewire can liberate emboli, especially in saphenous vein grafts. Placement of a balloon catheter requires pre-placement of a guidewire in this prior art approach.
This invention is a device and a method that creates a seal to prevent the flow of blood during the treatment of vascular disease. A seal may be formed between the distal inside diameter of a sheath or catheter such as a guide catheter and within a vessel, such as an artery or vein. An elongated device having a distal portion extending from the catheter and having a fluid impermeable membrane disposed about at least the distal end of the device is used to seal the vessel. This invention is also a system in which the device occludes blood flow and includes a distal protection device which is deployed to filter or remove embolic debris.
In one aspect, this invention is a method of performing an intravascular procedure at a treatment site in a vessel of a patient. The method includes providing a sealing device having proximal and distal ends, a distal sealing portion and a proximal sealing portion and having a lumen extending therethrough. The method further includes introducing a guide catheter into the vessel, advancing the guide catheter through the vessel until a distal end of the guide catheter is at a desired location proximal of the treatment site, introducing the sealing device into a lumen of the guide catheter, advancing the sealing device through the lumen of the guide catheter until the distal sealing portion extends from the distal end of the guide catheter, and occluding the flow of blood through the vessel with the sealing device. After blood flow has been occluded the method includes advancing a distal protection device through the lumens of the guide catheter and the sealing device and through the vessel to a location distal to the treatment site, deploying the distal protection device, withdrawing the distal sealing portion of the sealing device into the guide catheter, advancing a vascular treatment device through the guide catheter to the treatment site, and performing the intravascular procedure with the treatment device.
The distal sealing portion of the sealing device may be expandable from a delivery configuration to a deployed configuration. The proximal sealing portion of the sealing device may have a first diameter and the distal sealing portion may have a second diameter when extended from the distal end of the guide catheter, the second diameter being larger that the first diameter. The sealing device may comprise metal wire, which may comprise nitinol. The sealing device may also have a control element connected adjacent at least one of the distal and proximal ends of the sealing device, and this control element may be a wire or a tube.
The control element may comprise an elongate proximal portion of the sealing device having a length sufficient to extend outside the patient during advancement of the sealing device. The sealing device may comprise a flexible membrane. The distal sealing portion of the sealing element may comprise a flexible membrane which is folded into the lumen of the sealing device, wherein the sealing device further includes a deployment member, and wherein the step of occluding the flow of blood comprises advancing the deployment member through the lumen of the sealing device to push the folded membrane out of the lumen of the sealing device. There may be at least one flow window between the lumen of the sealing device and an exterior surface of the sealing device. When the distal sealing portion is expandable from a delivery configuration to a deployed configuration, there may be a means to delay expansion of the distal sealing portion of the sealing device and this means may include longitudinal restraining elements positioned adjacent the distal sealing portion.
The step of advancing the sealing device may comprise inflating a balloon portion of a balloon catheter in the lumen of the sealing device until the sealing device is secured to the balloon catheter and then advancing the balloon catheter through the lumen of the guide catheter. The sealing device also may include means to bias the proximal sealing portion outwardly to seal against the lumen of the guide catheter, and this biasing means may comprise a spring wire, open cell foam, or a locally thinned portion of the proximal sealing portion. When the treatment site is located adjacent an ostium of the vessel, the distal sealing portion of the sealing device may be provided with a first section with a first diameter sized to seal the vessel proximal to the ostium and a second section with a second larger diameter.
In another aspect, this invention is a method of occluding the flow of blood in a vessel of a patient comprising introducing an elongate sheath into the vessel, the sheath having an inner wall defining a lumen extending therethrough, advancing the sheath through the vessel until a distal end of the sheath is at a desired location in the vessel, introducing a sealing device into the lumen of the sheath, the sealing device having a proximal sealing portion which seals against the inner wall of the sheath and a self-expanding distal sealing portion and having a lumen extending therethrough, and advancing the sealing device through the lumen of the sheath until the distal sealing portion extends from a distal end of the sheath and expands to seal against the wall of the vessel to occlude blood flow.
In another aspect, this invention is a sealing device for use in combination with a catheter to occlude fluid flow through a body lumen comprising an elongate body having a distal sealing portion and a proximal sealing portion and a lumen extending therethrough, the proximal sealing portion being sized to seal against a lumen of the catheter and the distal sealing portion being sized to seal against the body lumen when the distal sealing portion is extended from a distal end of the catheter.
In another aspect, this invention is a system for occluding the flow of blood in a vessel of a human vascular system comprising a catheter having proximal and distal ends and a lumen, and a sealing device having a proximal sealing portion and a distal sealing portion and a lumen, the proximal sealing portion being sized to seal against the lumen of the catheter and the distal sealing portion being sized to seal against the wall of the vessel when the distal sealing portion is extended from the distal end of the catheter.
In another aspect, this invention is a system for protecting a patient from emboli released during an intravascular procedure performed at a treatment site in a vessel of a patient comprising a guide catheter having proximal and distal ends and a lumen, a sealing device having a distal sealing portion and a proximal sealing portion and a lumen, the proximal sealing portion being sized to seal against the lumen of the guide catheter and the distal sealing portion being sized to seal against the wall of the vessel at a location proximal to the treatment site when the distal sealing portion is extended from the distal end of the guide catheter, and a distal protection device sized to be delivered through the lumens of the guide catheter and sealing device to a location in the vessel distal to the treatment site.
In another aspect, this invention is a system for protecting a patient from emboli released during an intravascular procedure performed at a treatment site in a vessel of a patient comprising a guide catheter having proximal and distal ends and a lumen, a sealing device having a lumen and having a proximal portion including proximal sealing means for sealing against the lumen of the guide catheter and a distal portion including distal sealing means for sealing against the wall of the vessel at a location proximal to the treatment site when the distal portion is extended from the distal end of the guide catheter and a distal protection device sized to be delivered through the lumens of the guide catheter and sealing device to a location in the vessel distal to the treatment site. The proximal sealing means may comprise a spring wire or open cell foam. A distance between a wall of the lumen of the sealing device and an exterior surface of a first section of the proximal portion defines a first wall thickness and a distance between the wall of the lumen of the sealing device and an exterior surface of a second section of the proximal portion defines a second wall thickness which is less than the first wall thickness, the second section being biased radially outwardly, the proximal sealing means comprising the second section. The distal sealing means may comprise a self-expanding metal.
In another aspect, this invention is a system for protecting a patient from emboli released during an intravascular procedure performed at a treatment site in a vessel of a patient comprising a guide catheter having proximal and distal ends and a lumen, a sealing device having a distal sealing portion and a proximal sealing portion and a lumen, the proximal sealing portion being sized to seal against the lumen of the guide catheter and the distal sealing portion being sized to seal against the wall of the vessel at a location proximal to the treatment site when the distal sealing portion is extended from the distal end of the guide catheter, a delivery catheter having distal and proximal ends and a lumen, the delivery catheter being sized to be delivered through the lumens of the guide catheter and sealing device to a location in the vessel where its distal end is distal to the treatment site, and an elongate support member carrying an embolic protection device, the elongate support member and embolic protection device being sized to be slideably accommodated within the lumen of the delivery catheter, the embolic protection device being expandable from a delivery configuration when contained within the delivery catheter to a deployed configuration when extended from the distal end of the delivery catheter.
In another aspect, this invention is a method of performing an intravascular procedure at a treatment site in a vessel of a patient comprising providing a sealing device having proximal and distal ends, a distal sealing portion and a proximal sealing portion and having a lumen extending therethrough, introducing a guide catheter into the vessel, the guide catheter having proximal and distal ends and a lumen and a valve connected at the proximal end for opening and closing the lumen of the guide catheter to fluid flow, advancing the guide catheter through the vessel until the distal end of the guide catheter is at a desired location proximal of the treatment site, introducing the sealing device into the lumen of the guide catheter, advancing the sealing device through the lumen of the guide catheter until the distal sealing portion extends from the distal end of the guide catheter, blocking antegrade blood flow through the vessel with the sealing device, opening the valve on the guide catheter to create retrograde blood flow through the vessel, after antegrade blood flow has been blocked advancing a distal protection device through the lumens of the guide catheter and the sealing device and through the vessel to a location distal to the treatment site, deploying the distal protection device, withdrawing the distal sealing portion of the sealing device into the guide catheter, advancing a vascular treatment device through the guide catheter to the treatment site, and performing the intravascular procedure with the treatment device.
In another aspect, this invention is a method of performing an intravascular procedure at a treatment site in a vessel of a patient comprising providing a sealing device having proximal and distal ends, a distal sealing portion and a proximal sealing portion and having a lumen extending therethrough, introducing a guide catheter into the vessel, the guide catheter having proximal and distal ends and a lumen and a suction device connected to the lumen, advancing the guide catheter through the vessel until the distal end of the guide catheter is at a desired location proximal of the treatment site, introducing the sealing device into the lumen of the guide catheter, advancing the sealing device through the lumen of the guide catheter until the distal sealing portion extends from the distal end of the guide catheter, blocking antegrade blood flow through the vessel with the sealing device, operating the suction device to create retrograde blood flow through the vessel, after antegrade blood flow has been blocked advancing a distal protection device through the lumens of the guide catheter and the sealing device and through the vessel to a location distal to the treatment site, deploying the distal protection device, withdrawing the distal sealing portion of the sealing device into the guide catheter, advancing a vascular treatment device through the guide catheter to the treatment site, and performing the intravascular procedure with the treatment device.
In another aspect, this invention is a system for creating retrograde flow of blood in a vessel of a human vascular system comprising a catheter having proximal and distal ends and a lumen and a valve connected at the proximal end for opening and closing the lumen of the catheter to fluid flow, and a sealing device having a proximal sealing portion and a distal sealing portion and a lumen, the proximal sealing portion being sized to seal against the lumen of the catheter and the distal sealing portion being sized to seal against the wall of the vessel when the distal sealing portion is extended from the distal end of the catheter.
In another aspect, this invention is a system for creating retrograde flow of blood in a vessel of a human vascular system comprising a catheter having proximal and distal ends and a lumen, a suction device connected to the lumen of the catheter, and a sealing device having a proximal sealing portion and a distal sealing portion and a lumen, the proximal sealing portion being sized to seal against the lumen of the catheter and the distal sealing portion being sized to seal against the wall of the vessel when the distal sealing portion is extended from the distal end of the catheter.
In another aspect, this invention is a method of delivering an embolic protection device to a desired location distal to a treatment site in a vessel of a patient. The method includes providing a sealing device having proximal and distal ends, a distal sealing portion and a proximal sealing portion and having a lumen extending therethrough, introducing a guide catheter into the vessel, advancing the guide catheter through the vessel until a distal end of the guide catheter is at a desired location proximal of the treatment site, introducing the sealing device into a lumen of the guide catheter, advancing the sealing device through the lumen of the guide catheter until the distal sealing portion extends from the distal end of the guide catheter, occluding the flow of blood through the vessel with the sealing device, and after blood flow has been occluded advancing a distal protection device through the lumens of the guide catheter and the sealing device and through the vessel to the desired location distal to the treatment site.
In another aspect, this invention is a method of occluding the flow of blood in a vessel of a patient comprising providing a sealing device having proximal and distal ends, a distal sealing portion and a proximal sealing portion and having a lumen extending therethrough, introducing a guide catheter into the vessel, advancing the guide catheter through the vessel until a distal end of the guide catheter is at a desired location proximal of the treatment site, introducing the sealing device into a lumen of the guide catheter, and advancing the sealing device through the lumen of the guide catheter until the distal sealing portion extends from the distal end of the guide catheter and expands to seal against a wall of the vessel.
The terms “distal” and “proximal” as used herein refer to the relative position of the guidewire, catheters, and guide seal in a lumen. “Proximal” refers to a location upstream and “distal” refers to a location downstream. Flow of blood through a lumen normally moves from the proximal to the distal portions of the device of this invention, however, the device interrupts this flow and a retrograde flow may be established.
The Figures describe various embodiments. Elements that vary from one embodiment to another but otherwise are similar in shape, size, relative placement, or function are denoted by suffices “a”, “b”, “c”, etc., and may be referred to in a general way by a number without its suffix.
The present invention is a device for occluding blood flow in a vessel at a location proximal to a treatment site in the vessel, thus preventing embolic material from moving distally in the vessel, prior to deployment of an embolic protection device positioned distally of the treatment site. The device includes a guide seal that has a proximal portion that seals within the lumen of a guide catheter and a distal portion that expands when deployed beyond the distal end of the guide catheter to seal within a vessel so that a fluid tight seal is obtained. The guide seal stops blood flow through the vessel and is deployed without causing damage to the vasculature. A filtration device or other distal protection device can then be advanced through the guide seal, down the vessel, and across a lesion or stenosis. Because of the occlusion by the guide seal there is little or no flow through the stenotic site when it is being crossed by the distal protection device or its delivery catheter. A proximal wire or other control means extends axially and controls actuation of the guide seal by its position relative to the distal end of the guide catheter.
The guide catheter, guide seal, control wires and other components of the device of this invention comprise biocompatible materials, and these include metals and polymeric materials. These materials can be treated to impart biocompatibility by various surface treatments, as known in the art. Desired components also may be coated with antithrombogenic materials such as heparin or materials to enhance slipperiness such as hydrophilic coatings.
Wire is selected on the basis of the characteristic desired, i.e., stiffness or flexibility, and the properties can depend upon both the diameter of the wire and its cross-sectional shape. The size, thickness and composition of elastic materials are selected for their ability to perform as desired as well as their biocompatibility. It is to be understood that these design elements are all within the scope of this invention.
The guide seal comprises an elongate body defining an interior cavity which, when deployed in a vessel, is large enough to allow passage of a catheter used to deliver a distal protection device such as an expandable filter or balloon. It has a sealing membrane around at least the portion of the guide seal which extends distally of the guide catheter when the guide seal is deployed. In a preferred embodiment, the guide seal has a vessel sealing portion adjacent its distal end and a guide catheter sealing portion which remains in the lumen of the guide catheter when the guide seal is deployed. The guide catheter sealing portion lies within the guide catheter and can expand to seal within the guide catheter. Typically, the vessel sealing portion ranges in diameter from about 2 to about 10 mm and has a larger diameter than the guide sealing portion, which ranges in diameter from about 1.27 mm to about 2.8 mm (0.050 inch to 0.110 inch). The guide seal is open at its distal end to provide for the passage of another catheter or a distal protection element, as described further below.
The guide seal may comprise any material that is suitably flexible and resilient and may comprise braided, knitted, woven, or non-woven fabrics, or polymer films, such as polyester, nylon, and the like. The guide seal may comprise stainless steel, titanium and its alloys, cobalt-chromium-nickel-molybdenum-iron alloy (commercially available under the trade designation Elgiloy™), carbon fiber and its composites, and engineered polymers such as liquid crystal polymers, polyetheretherketone (PEEK), polyimide, polyester, and the like. A preferred shape memory metal comprises nickel and titanium and is known as “nitinol”. This is commercially available in various dimensions.
In a preferred embodiment, the guide seal is formed by braiding 16 nitinol wires measuring about 0.001 inch by 0.003 inch (0.025 mm by 0.076 mm) with a pick count of about 50 to 100. Alternatively, round wires having a diameter of about 0.0015 inch (0.038 mm) diameter, (range of 0.0007 inch to 0.002 inch, or 0.018 mm to 0.054 mm) with various pick counts, can be used as needed to achieve adequate combination of flexibility and support of a covering or attached membrane for fluid sealing. Braiding options are well known in the catheter industry and also described in co-pending, commonly assigned U.S. Ser. No. 08/748,066 (Mazzochi et al.), hereby incorporated herein by reference. The guide seal is preferably about 6 inches (15.4 cm) long with a range from about 2 to 20 inches (about 5.1 to 50.8 cm).
A sealing membrane may be cast onto the wire of the elongate body of the guide seal by using an elastomer that allows free diameter expansion from a smaller constrained diameter. A cast membrane may be made using a two part silicone dispersion such as that commercially available as Med-6640 from Nusil Technology, Carpinteria, Calif. Use of dipping technology is well known in the industry. Alternatively, a thin membrane may be attached to or carried by the braid by means of adhesives, sutures, thermowelding or other techniques know by those of skill in the art for covered stents and vascular grafts. U.S. Pat. Nos. 6,139,573 (Sogard et al.) and 5,824,044 (Quiachon et al.) teach the use of polymer and ePTFE membranes attached to either side of an expandable metal stent. U.S. Pat. No. 6,375,787 (Schneider) teaches attachment of elastic tubular sleeves on expandable wire braided stents. Numerous polymer materials may be used such as PTFE, urethanes, silicones, polyethylene, and elastomeric materials to form a fluid impermeable layer or membrane. Suitable elastomeric materials include polyamide block copolymers (commercially available under the trade designation “PEBAX”).
In a preferred embodiment where nitinol braided wire is used, the proximal and distal diameters of the elongate body of the guide seal may be heat set to limit the expansion force against the guide catheter and against the vessel. Adequate force is needed to produce a good seal, but too much expansion force can cause drag, making it difficult to move the guide seal through the lumen guide catheter. Such heat set parameters are described in patent application WO 96/01591 (Mazzochi et al.) and well known in the art. The proximal portion of the expandable member that seals to the guide catheter would be provided with an outside diameter in the range of 4 to 14 French in the self expanded state depending on the guide catheter diameter and the sealing pressure needed. A typical guide catheter or sheath is 6 to 10 French outside diameter, with 6 to 8 French being most common. In the case of an 8 French guide catheter, the proximal section of the guide seal may have a diameter of 6 French, for example. The distal portion of the guide seal (i.e., that which will seal against the inside of the vessel) would have an expanded diameter 10 to 20% bigger than the vessel diameter. For example, typical saphenous vein grafts have an inside diameter ranging from 3 to 5 mm and carotid arteries have inside diameters ranging from 5 to 7 mm.
Suitable materials for the proximal control wire include stainless steel, nitinol, alloys such as cobalt-chromium-nickel-molybdenum-iron alloy (commercially available under the trade designation Elgiloy™) or other resilient material. In a preferred embodiment, the proximal wire is a stainless steel wire in the range of 0.010 to 0.018 inch (0.025 cm to 0.046 cm) diameter, preferably 0.014 inch (0.036 cm) and preferably about 170 cm long. This wire preferably is coated with polytetrafluoroethylene (PTFE) for lubricity.
A distal protection element may be used in conjunction with the guide catheter and guide seal of this invention. A distal protection element includes any device to be deployed in a lumen or vessel of a patient in a minimally invasive procedure. Suitable distal protection elements include occlusive devices and filtration devices. Occlusive devices include balloons, i.e., elements that are designed to expand within a vessel. Filters include, for example, those disclosed in commonly assigned, co-pending U.S. Ser. No. 10/602,271, entitled “Slideable Vascular Filter”, U.S. Ser. No. 10/093,572, entitled “Distal Protection Devices Having Controllable Wire Motion”, and U.S. Ser. No. 10/132,562, entitled “Vascular Protection Devices and Methods of Use”, hereby incorporated herein by reference.
The distal protection element used in conjunction with the guide seal and guide catheter may comprise a self-expanding material. These include metals such as stainless steel, titanium and its alloys, cobalt-chromium-nickel-molybdenum-iron alloy (commercially available under the trade designation Elgiloy™), carbon fiber and its composites, and engineered polymers such as liquid crystal polymers, polyetheretherketone (PEEK), polyimide, polyester, silk, and the like. A shape memory metal is particularly suitable for those applications when it is desired for an element, such as a filter, to assume a pre-determined three-dimensional shape or for a guidewire to maintain a pre-determined curvature. A preferred shape memory metal is nitinol. For example, nitinol tubular braid can be heat set into a desired shape, compressed for delivery to a site, and then released to form the heat-set shape.
One or more radiopaque markers may be positioned at various locations on the guide seal, the guide catheter, or the distal protection element. These radiopaque markers or marker bands comprise a material that will strongly absorb X-rays and thus assist in proper placement. Suitable radiopaque materials include platinum, gold, iridium, tungsten, bismuth subcarbonate, barium sulfate, and others known to one of skill in the art.
The various embodiments of the invention will now be described in connection with the figures. It should be understood that for purposes of better describing the invention the drawings have not been made to scale. Further, some of the figures include enlarged or distorted portions for the purpose of showing features that would not otherwise be apparent. The material comprising the guide seal is indicated by cross-hatching in some of the figures but is omitted from others for simplicity and to show particular features of the device.
As is known in the art, in treatment of a blood vessel, such as a saphenous vein by-pass graft, a physician first places an introducer catheter into the femoral artery. This introducer catheter is used to position a guide catheter and guidewire so that other catheters can be moved along the guidewire to a treatment site. For simplicity, the guidewire, guide catheter, and introducer catheter are not shown.
The use of the device of this invention can be understood with reference to
A Y connector with hemostasis valve typically is attached to the proximal end of the guide catheter for ease of device passage and reduced blood loss. In a preferred embodiment, control wire 5, which is connected to the proximal end of the guide seal, passes through the Y connector 7. Hemostasis valve 9 is at the proximal end of Y connector 7. Optional locking syringe 8 is connected to a side arm of the Y connector. The purpose of the locking syringe is to create suction and flow reversal if desired during the time the vessel is sealed. The locking syringe operates by withdrawal of a plunger until the plunger locks into position, thus creating suction in the syringe. This is done while tightening hemostasis valve 9 to prevent entry of air into the guide.
The use of the device is as follows. The physician first places an introducer catheter into the femoral artery. A guidewire is then advanced through the femoral artery into the aorta. The guide catheter is then advanced over the guidewire until the distal tip of the guide catheter is in the ostium of the vessel. The guidewire is then removed. The guide seal is then loaded into the proximal end of the guide catheter through the Y connector with the aid of an introducer and advanced distally by moving control wire 5 in a distal direction. The guide seal is advanced until its distal tip is just proximal of the distal tip of the guide catheter. Then, the embolic protection device of choice which is typically carried on an elongate support member such as a guidewire and delivered within a delivery catheter is advanced through the guide catheter along side control wire 5 until its distal end is just proximal of the distal end of the guide catheter. At this position the embolic protection device is within the lumen of the guide seal. The guide seal is then advanced distally until sufficient length is extended to ensure full diameter contact of the distal sealing portion with the inside diameter of the vessel wall. When the guide seal is used in the ostium of a coronary artery it may be provided with structural features which prevent the distal sealing portion from expanding too rapidly which could result in the distal tip of the guide catheter being dislodged from the ostium. These features are discussed in detail hereafter. Deployment of the distal sealing portion of the guide seal results in a seal being formed between the guide catheter and the vessel which occludes the flow of blood through the vessel. The proximal end of the guide catheter may be closed to stop flow in the vessel or may be opened to atmosphere to achieve retrograde flow from the vessel proximally through the guide catheter during vessel sealing. Alternatively, the hemostasis valve on the Y connector may be closed and the syringe plunger on the Y connector sidearm locked in a withdrawn position to cause vacuum in the syringe barrel and resultant flow reversal in the vessel and proximally through the guide. The embolic protection device is now advanced through the guide seal and through the vessel across the lesion to a point distal to the treatment site. Any embolic material dislodged by passage or deployment of the embolic protection device is prevented from flowing distally due to no flow or reverse flow in the vessel. In the case of retrograde flow embolic material can be flushed proximally through the guide catheter. Once the embolic protection device is deployed and its delivery catheter (if used) is removed, the guide seal is retracted proximally into the guide catheter and optionally removed from the patient in either an over-the-wire or rapid exchange manner. At this time if the embolic protection device is a filter, flow is re-established in the vessel and any embolic material in the vessel is carried by the flow into the filter where it is captured for later removal. If the embolic protection device is an occlusive device such as a balloon the embolic material is prevented from escaping the vessel until a suction catheter is deployed for its removal or the guide catheter may be used for extraction by connecting a suction source to its proximal end or to the side arm of the Y connector.
It is to be understood that the device of this invention could be used in any desired vessel, such as, for example, the right main coronary artery, the bracheocephalic artery, or renal arteries.
Various alternative embodiments of guide seals and particular features thereof are described in connection with FIGS. 3 to 16.
The guide seal may be constructed with special features which enhance the effectiveness of the seal between the proximal or guide catheter sealing portion and the inner wall of the guide catheter.
In some instances, a patient may not be able to tolerate static or reversed blood flow for any length of time. In this case, it is possible to provide an option to rapidly establish blood flow in the vessel during use of the guide seal.
If the system disclosed herein is used in the ostium of an artery, such as a coronary artery, it is desirable to maintain the position of the distal end of the guide catheter within the ostium during the course of the procedure in order to provide access to the artery for various interventional devices. During deployment of the distal vessel sealing portion of the guide seal by advancing the guide seal distally it is possible to dislodge the distal end of the guide catheter from the ostium if the distal end of the guide seal self-expands too quickly. This is because the distal end of the guide seal will engage the vessel wall before the entire vessel sealing portion has been advanced distally out of the guide catheter. Further advancement of the guide seal after the vessel wall is engaged can result in dislodging the distal end of the guide catheter from the ostium. Thus, it is preferred to have a means to control the expansion of the distal end of the guide seal.
One of skill in the art recognizes that many different shapes, compositions, and diameters of wires and ribbons can be used to obtain the desired effect, which is greater control over the expansion of the distal end of the guide seal into the ostium.
The device and method of this invention is particularly useful during interventional procedures such as in cardiology, radiology, and neuroradiology procedures.
Although particular embodiments of the invention have been disclosed herein in detail, this has been done for the purposes of illustration only, and is not intended to be limiting with respect to the scope of the appended claims. It is contemplated that various substitutions, alterations, and modifications may be made to the embodiments of the invention described herein without departing from the spirit and scope of the invention as defined by the claims.
This application is a divisional of application Ser. No. 10/194,355, filed Jul. 12, 2002, which is hereby incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| Parent | 10194355 | Jul 2002 | US |
| Child | 11801215 | May 2007 | US |
